FDA Inspection 1251840 — Janice B. Lima Maribona, D.O.
The FDA completed an inspection of Janice B. Lima Maribona, D.O. on Oct 8, 2024 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 8, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miami, FL (United States)
Additional Details
Clinical BA/BE